Stock comparison

ALNYvsBIIB

Alnylam Pharmaceuticals IncvsBiogen Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

ALNY

Alnylam Pharmaceuticals Inc

$313.79

-19.78%

Biotechnology$41.4BNASDAQ

BIIB

Biogen Inc

$187.88

+6.91%

Biotechnology$25.8BNASDAQ

60-day price, rebased to 100

ALNY -7.18% · BIIB +6.64%

Round-by-round

ALNY 3·BIIB 2· 1tie

EdgeBIIB

Valuation upside

-30.50% vs +7.40% to DCF fair value

EdgeALNY

Balance-sheet strength

Altman Z 5.77 vs 3.10

Tie

Fundamental quality

Piotroski 6.00 vs 6.00 (of 9)

EdgeALNY

Growth + margins

Rule-of-40 77.70 vs 23.00

EdgeBIIB

60-day momentum

-7.18% vs +6.64% price return

EdgeALNY

Market-cap liquidity

$41.4B vs $25.8B

Verdict

Across6categories,ALNYtakes the edge with3wins to2 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onALNYorBIIB

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.